JJ KELLER 59978 - Multi-Drug Screen Card - 5 Panel w/ Adulterants

• Specific for those who wish to do a non-regulated "DOT replica" rapid test
• Purposefully designed to aid in wicking and prevent flooding
• CLIA and FDA approved
• The patented key-operated trigger system keeps the collector's control and prevents donor activation and tampering
• The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in urine
• Easy-to-read results in minutes
• Negative results in one minute or less
• Each multi-drug urine drug test is expiration dated (18 months from date of manufacture)
• Price per box of 25 tests

Split drug test can be used for the simultaneous detection of the following drugs and their metabolites, but is not intended to be used for a drug test required by Part 382:

59978 – CLIA waived & FDA approved
Amphetamine (AMP) 500 ng/ml
Cocaine (COC) 150 ng/ml
Methamphetamine (MET) 500 ng/ml
Opiates (OPI) 300 ng/ml
Marijuana (THC) 50 ng/ml

59979 – CLIA waived & FDA approved
Amphetamine (AMP) 500 ng/ml
Barbiturates (BAR) 300 ng/ml
Buprenorphine (BUP) 10 ng/ml
Benzodiazepine (BZO) 300 ng/ml
Cocaine (COC) 150 ng/ml
Ecstasy (MDMA) 500 ng/ml
Methamphetamine (MET) 500 ng/ml
Methadone (MTD) 300 ng/ml
Opiates (OPI) 300 ng/ml
Oxycodone (OXY) 100 ng/ml
Phencyclidine (PCP) 25 ng/ml
Marijuana (THC) 50 ng/ml

Note: This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Liquid chromatography/mass spectrometry (LC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when non-negative (preliminary positive) results are indicated on the screening device.

Due to export restrictions, these medical devices cannot be shipped outside of the USA without written consent.